drugset / Trial / NCT01302002

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

NCT01302002

Non-randomizedSingle-groupOpen-labelBasic science

Summary

The study will test metformin in patients with early breast cancer. Blood and tissue will be collected before and after the use of metformin.

Timeline

Start
2011-01
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg

Indications